BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27499103)

  • 1. Preliminary investigation of five novel long non-coding RNAs in hepatocellular carcinoma cell lines.
    Xia J; Inagaki Y; Sawakami T; Song P; Cai Y; Hasegawa K; Sakamoto Y; Akimitsu N; Tang W; Kokudo N
    Biosci Trends; 2016 Sep; 10(4):315-9. PubMed ID: 27499103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma.
    Moyo B; Nicholson SA; Arbuthnot PB
    Virus Res; 2016 Jan; 212():103-13. PubMed ID: 26239319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
    Gong X; Wei W; Chen L; Xia Z; Yu C
    Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma.
    Yu TT; Xu XM; Hu Y; Deng JJ; Ge W; Han NN; Zhang MX
    World J Gastroenterol; 2015 Jun; 21(23):7208-17. PubMed ID: 26109807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology.
    Zhang Q; Matsuura K; Kleiner DE; Zamboni F; Alter HJ; Farci P
    J Transl Med; 2016 Nov; 14(1):328. PubMed ID: 27894309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.
    Pan YF; Qin T; Feng L; Yu ZJ
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):96-101. PubMed ID: 23392715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
    Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
    Ma Y; Luo T; Dong D; Wu X; Wang Y
    Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of long noncoding RNAs in hepatocellular carcinoma.
    Shi L; Peng F; Tao Y; Fan X; Li N
    Virus Res; 2016 Sep; 223():131-9. PubMed ID: 27374059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
    Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
    Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
    Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
    Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
    Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
    Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma.
    Liu H; Zhao P; Jin X; Zhao Y; Chen Y; Yan T; Wang J; Wu L; Sun Y
    Mol Med Rep; 2019 Jul; 20(1):573-583. PubMed ID: 31115573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
    Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
    Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.
    Zhang H; Zhu C; Zhao Y; Li M; Wu L; Yang X; Wan X; Wang A; Zhang MQ; Sang X; Zhao H
    Oncotarget; 2015 Dec; 6(41):43770-8. PubMed ID: 26540467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.